Disseminated Candidiasis

• FDA approval · 2022-06-13
  FDA Approved: VORICONAZOLE — Supplemental Application (Zydus Lifesciences Limited)

  The FDA approved a supplemental application for Voriconazole from Zydus Lifesciences Limited, updating the approval for this generic antifun…

• FDA approval · 2020-07-31
  FDA Tentative Approval: MYCAMINE — Supplemental Application (Astellas Pharma US, Inc.)

  The FDA granted tentative approval for a supplemental application for Mycamine (micafungin sodium) from Astellas Pharma US, enabling potenti…

• FDA approval · 2016-05-31
  FDA Approved: VORICONAZOLE — Original Application (Lupin Pharmaceuticals,Inc.)

  FDA approval of Lupin's original application for a generic voriconazole product used to treat invasive fungal infections, including invasive…

• FDA approval · 2012-03-14
  FDA Approved: FLUCONAZOLE — Supplemental Application (Hospira, Inc)

  The FDA approved a supplemental application for fluconazole submitted by Hospira, Inc., authorizing changes to the product under the ANDA.